OCGN · Ocugen, Inc. · Documents

May 10

Current report 8-K

Change to shareholders' rights, Charter or bylaw amendment, or fiscal year change

Apr 29

Annual report 10-K/A Ended Dec 31

Annual report for the period ended Dec 31, 2023

Apr 29

Current report 8-K Events of Apr 26

Regulation FD disclosure

Apr 18

Registration statement S-3

Registration statement

Apr 16

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $6.04M ▲ 142.6% Net loss $63.08M Diluted EPS -$0.26

Apr 8

Current report 8-K

Other events

Apr 2

Earnings call

Q4 2023 earnings call

Apr 2

Current report 8-K

Financial results

Apr 1

Current report 8-K

Earlier financial statements no longer reliable, Other events

Apr 1

Late filing notice NT 10-K

Late filing notice

Mar 21

Current report 8-K

Regulation FD disclosure

Mar 20

Current report 8-K Events of Mar 15

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change

Mar 18

Current report 8-K

Regulation FD disclosure, Other events

Feb 21

Current report 8-K

Regulation FD disclosure

Jan 8

Current report 8-K Events of Jan 2

Director or officer change, or executive pay

Dec 22

Current report 8-K

Other events

Nov 9

Current report 8-K

Financial results

Nov 9

Earnings call

Q3 2023 earnings call

Nov 9

Current report 8-K

Other events

Nov 9

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Net loss $14.16M Diluted EPS -$0.06

Nov 2

Current report 8-K

Delisting notice or listing transfer

Oct 10

Current report 8-K

Other events

Sep 19

Current report 8-K Events of Sep 15

Director or officer change, or executive pay

Sep 13

Current report 8-K

Other events

Aug 22

Earnings call

Q2 2023 earnings call

Aug 22

Current report 8-K

Financial results

Aug 21

Current report 8-K

Financial results

Aug 21

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Net loss $22.93M Diluted EPS -$0.10

Aug 15

Current report 8-K Events of Aug 14

Director or officer change, or executive pay

Aug 15

Late filing notice NT 10-Q

Late filing notice

Jun 27

Current report 8-K Events of Jun 23

Shareholder vote results

Jun 21

Proxy statement DEFA14A

Proxy statement

Jun 20

Proxy statement DEFA14A

Proxy statement

Jun 9

Proxy statement DEFA14A

Proxy statement

Jun 5

Current report 8-K

Other events

May 30

Proxy statement DEFA14A

Proxy statement

May 25

Current report 8-K Events of May 24

Entered into a material agreement

May 24

Proxy statement DEFA14A

Proxy statement

May 22

Proxy statement DEFA14A

Proxy statement

May 17

Proxy statement DEFA14A

Proxy statement

May 15

Proxy statement DEFA14A

Proxy statement

May 11

Proxy statement DEFA14A

Proxy statement

May 8

Proxy statement DEFA14A

Proxy statement

May 5

Earnings call

Q1 2023 earnings call

May 5

Current report 8-K Events of May 1

Financial results, Delisting notice or listing transfer

May 5

Current report 8-K

Other events

May 5

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Net loss $16.5M Diluted EPS -$0.07

Apr 20

Proxy statement DEF 14A Meeting Jun 9, 2023

Proxy statement

Apr 20

Annual report to holders ARS

Annual report to holders

Apr 14

Current report 8-K Events of Apr 13

Other events